Cook launches ART lab tutorial

Share this article:
Cook launches ART lab tutorial
Cook launches ART lab tutorial

In an effort to improve laboratory practices in the field of assisted reproduction technology (ART), Cook Medical launched a microsite and video lab tour.

The CookARTLab tour and site, launched formally May 4, allows visitors to watch demonstrations of ovum collection, sperm injection, embryo culture and other procedures associated with in-vitro fertilization, while also profiling specific Cook Medical products and devices used therein.

As specific equipment or devices are used in the tutorial, small pictures of Cook's products scroll up the left side of the video, and contain a link to the company's catalog page. For example, during an ovum aspiration procedure, Cook's EchoTip needles pop up next to the screen as they are used.

In addition to the step-by-step laboratory processes detailed in the tutorial, the microsite features a “Knowledge Center” for physicians, which provides “up-to-the-minute publishings” of relevant ART research, said Christina Anné, vice president of Cook's women's health strategic business.

The site's “Discussion” forum connects medical specialists — infertility and reproductive professionals — with Cook Medical product specialists, and allows physicians to discuss the various techniques and procedures of ART. Regarding oversight of the discussions, Gail McDaniel, digital marketing specialist at Cook, said certain key words are build into the posting function on the site that flag adverse event postings, for example. “We don't want to prevent discussions, but the forum is constantly monitored and we do have policies in place [for preventing off-label content],” said McDaniel.

Cook Medical launched an unbranded physician education site for Peyronie's disease in March of 2008, and hopes to launch future sites for its gynecological products and diagnostic imaging devices in the future, depending on budget allotments, said Anné.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...